Osterweis Capital Management Inc. acquired a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, HoldingsChannel reports. The institutional investor acquired 186,015 shares of the conglomerate’s stock, valued at approximately $35,432,000. Danaher accounts for approximately 1.7% of Osterweis Capital Management Inc.’s investment portfolio, making the stock its 18th largest position.
Several other institutional investors have also modified their holdings of the stock. BlackRock Inc. purchased a new position in shares of Danaher in the 2nd quarter valued at $10,492,520,000. Norges Bank acquired a new stake in Danaher during the 4th quarter worth $2,177,106,000. Generation Investment Management LLP purchased a new stake in Danaher in the second quarter valued at $1,287,949,000. Legal & General Group Plc purchased a new stake in Danaher in the second quarter valued at $801,056,000. Finally, Flossbach Von Storch SE purchased a new stake in Danaher in the second quarter valued at $747,260,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Trading Down 1.7%
NYSE DHR opened at $215.18 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The firm has a market cap of $151.27 billion, a PE ratio of 38.22, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm’s fifty day moving average is $196.49 and its two-hundred day moving average is $192.39.
Analysts Set New Price Targets
Several equities analysts have issued reports on DHR shares. Evercore reaffirmed an “outperform” rating and set a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. HSBC reduced their target price on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. DZ Bank began coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Finally, Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $228.91.
Get Our Latest Stock Report on Danaher
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
